.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Global private equity firms are actively competing for a significant share in India's leading maternal and child healthcare chain. This interest highlights the expanding value of the specialized healthcare market. Specifically, several international investors want to acquire a 25% stake in the hospital network. This landmark Cloudnine investment could value the maternal healthcare provider at approximately ₹10,000 crore ($1 billion).
Several global financial giants have entered the bidding process. These players include Warburg Pincus, KKR, TPG Capital, Advent International, CVC Capital Partners, and Permira. Additionally, domestic investor Kedaara Capital is actively participating in the race. Meanwhile, existing investor True North plans to make a complete exit from the firm. Consequently, this transaction will allow the early backer to fully monetize its decade-old investment. However, other prominent shareholders like Temasek and TPG Newquest will likely retain their current holdings. Together, these two entities control about 52% of the healthcare chain.
The healthcare chain has achieved rapid financial progress. For instance, the company earned a revenue of ₹2,000 crore alongside an EBITDA of ₹300 crore in the 2026 fiscal year. Furthermore, the firm recently expanded its reach by acquiring the maternal and fertility businesses of Apollo Health. This major consolidation strengthens its position across metropolitan hubs like Hyderabad, Bengaluru, and Chennai. Therefore, the fresh capital will support both regional expansion and international plans in the Middle East. Ultimately, these strategic moves will establish a highly integrated maternal care platform.
Q1: What is the estimated valuation of Cloudnine in this deal?
The proposed deal values the maternity and pediatric hospital chain at approximately ₹10,000 crore, which is equivalent to about $1 billion.
Q2: Who is running the sale process for this transaction?
Allegro Capital is managing the sale process, with initial bids expected by the first week of July.
Q3: Which existing investor plans to exit Cloudnine?
True North, which invested ₹400 crore in Cloudnine in 2015, plans to exit completely through this transaction.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Global private equity giants compete for a 25% stake in Cloudnine Hospitals, valuing India's premier maternity and childcare chain at $1 billion....
3 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
A prospective cohort study demonstrates that poor adolescent sleep quality, especially long sleep latency and reduced efficiency, increases dysmenorrhea severity in young adulthood. Addressing adolescent rest patterns offers a critical preventive avenue for clinicians.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
